Zobrazeno 1 - 10
of 273
pro vyhledávání: '"Kazue Takano"'
Autor:
Kazue Takano
Publikováno v:
Endocrine Journal, Vol 71, Iss 10, Pp 935-937 (2024)
Externí odkaz:
https://doaj.org/article/0ed9aa06a13448778fb3770004f426d6
Autor:
Satoshi Tanaka, Motohiko Aiba, William F. Young, Akiyo Tanabe, Naomi Hizuka, Jun Zhang, Kazue Takano
Publikováno v:
Endocrine Practice. 17:e73-e78
To describe the unique association of corticotropin-independent Cushing syndrome caused by cortisol- and androgen-secreting black adrenal cortical adenomas with myelolipomatous change.We report the clinical, laboratory, radiologic, and pathologic fin
Autor:
Izumi Fukuda, Makiko Kurimoto, Kazue Takano, Satoshi Tanaka, Y. Yamakado, Naomi Hizuka, Toko Muraoka
Publikováno v:
Endocrine Journal. 58:777-782
In Japan, the growth hormone (GH) assay has been standardized since April 2005 through use of a uniform recombinant human GH (rhGH) standard. Since then, GH values measured using the rhGH standard have been approximately 40% lower than previous value
Publikováno v:
Japanese Journal of Neurosurgery. 19:666-671
Autor:
Taichi Ezaki, Mitsuhide Naruse, Shunichi Morikawa, Daisuke Watanabe, Akiyo Tanabe, Kazue Takano
Publikováno v:
Hypertension Research. 32:807-815
Metabolic syndrome (MS) is an independent risk factor for chronic kidney diseases. As the renin-angiotensin system (RAS) is known to have a key role in renal damage, blockade of RAS may show renoprotective effects in MS. In this study, we investigate
Publikováno v:
Biochemical and Biophysical Research Communications. 381:283-287
To elucidate whether PTH(7-84), a degradation product of PTH(1-84), which inhibits PTH(1-84)-induced bone resorption, also exerts an antagonistic effect on the kidney, we studied the effect of PTH(7-84) on PTH(1-34)-induced production of 1,25-(OH) 2
Autor:
Yoshiaki Azuma, Takao Obara, Kishiko Nakajima, Seiichi Kosaka, Kazue Takano, Ken-ichi Umino, Kanji Sato
Publikováno v:
Journal of Bone and Mineral Metabolism. 27:224-233
The pathogenesis of primary hyperparathyroidism (I degrees -HPT) and secondary hyperparathyroidism (II degrees -HPT) remains to be elucidated. To characterize their pathophysiology, we investigated the effects of calcium and phosphate on cell prolife
Publikováno v:
Endocrine Journal. 56:561-570
Patients with growth hormone (GH) deficiency (GHD) have a clinical feature of visceral adiposity and it has been reported that these patients have an increased active cortisol (F)/inactive cortisone (E) metabolite ratio. 11beta-hydroxysteroid dehydro
Publikováno v:
Endocrine Journal. 56:1009-1018
Although cardiovascular complications are the major determinant of the prognosis of Cushing's syndrome (CS), factors contributing to the cardiovascular lesions are still unclear. We investigated clinical factors determining cardiac function in patien
Publikováno v:
Endocrine Journal. 56:391-397
Painless thyroiditis is characterized by transient thyrotoxicosis with complete recovery. Some patients, however, have repeated episodes of thyrotoxicosis, for which the mechanism of recurrence is not clear. We therefore studied the clinical characte